Dr. Jeff Lievense has extensive fermentation process development and scale-up experience with industrial-scale plants involving a wide range of products. He joined Genomatica, a bioengineering technology leader for the chemical industry, in 2012, and led scale-up of its GENO BDO™ (1,4-butanediol) bioprocess.
Prior to that, he was Executive Vice President, Process Development, at Amyris from December 2007 until April 2012, where he led development and scale-up of its Biofene® (farnesene) bioprocess. From 1994 to November 2007, he was Vice President, Technology and Process Development and served in other technology management positions in the Research and Development organization of Tate & Lyle Plc, a global food and agricultural ingredients company. At Tate & Lyle, his organizations’ responsibilities included the fermentation R&D program, commercializing three large-scale industrial fermentation products, and developing and scaling a production process for Bio-PDO™ (1,3-propanediol) to 100 million pounds per year at a new plant in Loudon, Tennessee.
From 1993 to 1994, Dr. Lievense served as Vice President, Research and Operations and President, Bio-Business Incubator of Michigan for Michigan Biotechnology Institute, and from 1990 to 1993 as Director of Chemical Programs and Pathway Engineering for Genencor International. From 1982 to 1989, he held various process engineering, research scientist and product management positions at Eastman Kodak Company.
Dr. Lievense earned a Ph.D. in chemical engineering from Purdue University and a B.S. in chemical engineering from the University of Michigan. In 2014, he was honored by Purdue with its Outstanding Chemical Engineer award.